Exact Mass: 579.2553678
Exact Mass Matches: 579.2553678
Found 420 metabolites which its exact mass value is equals to given mass value 579.2553678
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Fumitremorgin A
An organic heterohexacyclic compound that is a mycotoxic indole alkaloid obtained by prenylation of the 10-hydroxy group of verruculogen.
Taurochenodeoxycholate-3-sulfate
C26H45NO9S2 (579.2535600000001)
Taurochenodeoxycholate-3-sulfate is a bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. Under normal circumstances, bile acid sulfation is a minor pathway. However in the presence of cholestasis, the fraction of the bile acid pool which is sulfated increases. Sulfation of bile acids increases the aqueous solubility of the amphipathic compounds and results in more efficient renal clearance as well as in decreased reabsorption from the intestinal lumen. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurochenodeoxycholate-3-sulfate is a bile salt formed in the liver by conjugation of chenodeoxycholate with taurine, usually as the sodium salt. Under normal circumstances, bile acid sulfation is a minor pathway. However in the presence of cholestasis, the fraction of the bile acid pool which is sulfated increases. Sulfation of bile acids increases the aqueous solubility of the amphipathic compounds and results in more efficient renal clearance as well as in decreased reabsorption from the intestinal lumen. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB] Taurochenodeoxycholate-3-sulfate is a bile salt found in urine[1].
Taurochenodeoxycholate-7-sulfate
C26H45NO9S2 (579.2535600000001)
Taurochenodeoxycholate-7-sulfate is a sulfated bile acid. Under normal circumstances, bile acid sulfation is a minor pathway. However in the presence of cholestasis, the fraction of the bile acid pool which is sulfated increases. Sulfation of bile acids increases the aqueous solubility of the amphipathic compounds and results in more efficient renal clearance as well as in decreased reabsorption from the intestinal lumen. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Taurochenodeoxycholate-7-sulfate is a sulfated bile acid. Under normal circumstances, bile acid sulfation is a minor pathway. However in the presence of cholestasis, the fraction of the bile acid pool which is sulfated increases. Sulfation of bile acids increases the aqueous solubility of the amphipathic compounds and results in more efficient renal clearance as well as in decreased reabsorption from the intestinal lumen. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (PMID: 11316487, 16037564, 12576301, 11907135) [HMDB] D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Beta-Casomorphin-5
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004723 - Endorphins
Z-Gly-Gly-Arg-AMC
Rzedowskin D
Celapanigine
(4-[(acetyloxy)methyl]-6-{(1E,3E)-5-[(2S,3S,5R,6R)-5-{[(2Z,4S)-4-(acetyloxy)pent-2-enoyl]amino}-3,6-dimethyltetrahydro-2H-pyran-2-yl]-3-methylpenta-1,3-dien-1-yl}-4-hydroxytetrahydro-2H-pyran-2-yl)acetic acid
1beta,2beta-diacetoxy-9alpha-benzoyloxy-13-nicotinoyloxy-beta-dihydroagarofuran
4,6-Diacetoxy-5a-(benzoyloxymethyl)-5-(3-pyridylcarbonyloxy)-2H-3,9a-methano-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-1-benzooxepin
4,6-Diacetoxy-10-(benzoyloxy)-5-(3-pyridylcarbonyloxy)-2H-3,9a-methano-3,4,5,5a,6,7,8,9-octahydro-2,2,5a,9-tetramethyl-1-benzooxepin
Tyr Arg Ile Glu
Tyr Ile Glu Arg
Ile Tyr Arg Glu
C32H41N3O7_5H,12H-3,4-Dioxa-5a,11a,15a-triazacyclooct[lm]indeno[5,6-b]fluorene-11,15(2H,13H)-dione, 1,10,10a,14,14a,15b-hexahydro-10a-hydroxy-7-methoxy-2,2-dimethyl-10-[(3-methyl-2-buten-1-yl)oxy]-5-(2-methyl-1-propen-1-yl)-, (5R,10S,10aR,14aS,15bS)
Tauroursodeoxycholate-3-sulfate
C26H45NO9S2 (579.2535600000001)
BA-151-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-151-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-151-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-151-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
3a-Sulfooxy-12a-hydroxy-5b-cholan-24-oyl-taurine
C26H45NO9S2 (579.2535600000001)
BA-152-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-152-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-152-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-152-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-152-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
2-((4R)-4-((3R,5R,7R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO9S2 (579.2535600000001)
2-((4R)-4-((3R,5R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO9S2 (579.2535600000001)
2-((4R)-4-((3R,5R,7S,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO9S2 (579.2535600000001)
Asp Phe Ile Trp
Asp Phe Leu Trp
Asp Phe Trp Ile
Asp Phe Trp Leu
Asp Ile Phe Trp
Asp Ile Trp Phe
Asp Leu Phe Trp
Asp Leu Trp Phe
Asp Pro Trp Tyr
Asp Pro Tyr Trp
Asp Trp Phe Ile
Asp Trp Phe Leu
Asp Trp Ile Phe
Asp Trp Leu Phe
Asp Trp Pro Tyr
Asp Trp Tyr Pro
Asp Tyr Pro Trp
Asp Tyr Trp Pro
Glu Glu Phe Arg
Glu Glu Arg Phe
Glu Phe Glu Arg
Glu Phe Arg Glu
Glu Phe Val Trp
Glu Phe Trp Val
Glu Ile Arg Tyr
Glu Ile Tyr Arg
Glu Leu Arg Tyr
Glu Leu Tyr Arg
Glu Arg Glu Phe
Glu Arg Phe Glu
Glu Arg Ile Tyr
Glu Arg Leu Tyr
Glu Arg Tyr Ile
Glu Arg Tyr Leu
Glu Val Phe Trp
Glu Val Trp Phe
Glu Trp Phe Val
Glu Trp Val Phe
Glu Tyr Ile Arg
Glu Tyr Leu Arg
Glu Tyr Arg Ile
Glu Tyr Arg Leu
Phe Asp Ile Trp
Phe Asp Leu Trp
Phe Asp Trp Ile
Phe Asp Trp Leu
Phe Glu Glu Arg
Phe Glu Arg Glu
Phe Glu Val Trp
Phe Glu Trp Val
Phe His Asn Tyr
Phe His Tyr Asn
Phe Ile Asp Trp
Phe Ile Trp Asp
Phe Leu Asp Trp
Phe Leu Trp Asp
Phe Met Pro Trp
Phe Met Trp Pro
Phe Asn His Tyr
Phe Asn Asn Trp
Phe Asn Trp Asn
Phe Asn Tyr His
Phe Pro Met Trp
Phe Pro Trp Met
Phe Arg Glu Glu
Phe Val Glu Trp
Phe Val Trp Glu
Phe Trp Asp Ile
Phe Trp Asp Leu
Phe Trp Glu Val
Phe Trp Ile Asp
Phe Trp Leu Asp
Phe Trp Met Pro
Phe Trp Asn Asn
Phe Trp Pro Met
Phe Trp Val Glu
Phe Tyr His Asn
Phe Tyr Asn His
His Phe Asn Tyr
His Phe Tyr Asn
His His Met Arg
His His Arg Met
His His Thr Trp
His His Trp Thr
His Met His Arg
His Met Arg His
His Asn Phe Tyr
His Asn Tyr Phe
His Arg His Met
His Arg Met His
His Thr His Trp
His Thr Trp His
His Trp His Thr
His Trp Thr His
His Tyr Phe Asn
His Tyr Asn Phe
Ile Asp Phe Trp
Ile Asp Trp Phe
Ile Glu Arg Tyr
Ile Glu Tyr Arg
Ile Phe Asp Trp
Ile Phe Trp Asp
Ile Met Met Trp
Ile Met Trp Met
Ile Arg Glu Tyr
Ile Arg Tyr Glu
Ile Trp Asp Phe
Ile Trp Phe Asp
Ile Trp Met Met
Ile Tyr Glu Arg
Leu Asp Phe Trp
Leu Asp Trp Phe
Leu Glu Arg Tyr
Leu Glu Tyr Arg
Leu Phe Asp Trp
Leu Phe Trp Asp
Leu Met Met Trp
Leu Met Trp Met
Leu Arg Glu Tyr
Leu Arg Tyr Glu
Leu Trp Asp Phe
Leu Trp Phe Asp
Leu Trp Met Met
Leu Tyr Glu Arg
Leu Tyr Arg Glu
Met Phe Pro Trp
Met Phe Trp Pro
Met His His Arg
Met His Arg His
Met Ile Met Trp
Met Ile Trp Met
Met Leu Met Trp
Met Leu Trp Met
Met Met Ile Trp
Met Met Leu Trp
Met Met Trp Ile
Met Met Trp Leu
Met Pro Phe Trp
Met Pro Trp Phe
Met Arg His His
Met Trp Phe Pro
Met Trp Ile Met
Met Trp Leu Met
Met Trp Met Ile
Met Trp Met Leu
Met Trp Pro Phe
Asn Phe His Tyr
Asn Phe Asn Trp
Asn Phe Trp Asn
Asn Phe Tyr His
Asn His Phe Tyr
Asn His Tyr Phe
Asn Asn Phe Trp
Asn Asn Trp Phe
Asn Gln Arg Tyr
Asn Gln Tyr Arg
Asn Arg Gln Tyr
Asn Arg Tyr Gln
Asn Trp Phe Asn
Asn Trp Asn Phe
Asn Tyr Phe His
Asn Tyr His Phe
Asn Tyr Gln Arg
Asn Tyr Arg Gln
Pro Asp Trp Tyr
Pro Asp Tyr Trp
Pro Phe Met Trp
Pro Phe Trp Met
Pro Met Phe Trp
Pro Met Trp Phe
Pro Trp Asp Tyr
Pro Trp Phe Met
Pro Trp Met Phe
Pro Trp Tyr Asp
Pro Tyr Asp Trp
Pro Tyr Trp Asp
Gln Asn Arg Tyr
Gln Asn Tyr Arg
Gln Arg Asn Tyr
Gln Arg Tyr Asn
Gln Tyr Asn Arg
Gln Tyr Arg Asn
Arg Glu Glu Phe
Arg Glu Phe Glu
Arg Glu Ile Tyr
Arg Glu Leu Tyr
Arg Glu Tyr Ile
Arg Glu Tyr Leu
Arg Phe Glu Glu
Arg His His Met
Arg His Met His
Arg Ile Glu Tyr
Arg Ile Tyr Glu
Arg Leu Glu Tyr
Arg Leu Tyr Glu
Arg Met His His
Arg Asn Gln Tyr
Arg Asn Tyr Gln
Arg Gln Asn Tyr
Arg Gln Tyr Asn
Arg Tyr Glu Ile
Arg Tyr Glu Leu
Arg Tyr Ile Glu
Arg Tyr Leu Glu
Arg Tyr Asn Gln
Arg Tyr Gln Asn
Thr His His Trp
Thr His Trp His
Thr Trp His His
Val Glu Phe Trp
Val Glu Trp Phe
Val Phe Glu Trp
Val Phe Trp Glu
Val Trp Glu Phe
Val Trp Phe Glu
Trp Asp Phe Ile
Trp Asp Phe Leu
Trp Asp Ile Phe
Trp Asp Leu Phe
Trp Asp Pro Tyr
Trp Asp Tyr Pro
Trp Glu Phe Val
Trp Glu Val Phe
Trp Phe Asp Ile
Trp Phe Asp Leu
Trp Phe Glu Val
Trp Phe Ile Asp
Trp Phe Leu Asp
Trp Phe Met Pro
Trp Phe Asn Asn
Trp Phe Pro Met
Trp Phe Val Glu
Trp His His Thr
Trp His Thr His
Trp Ile Asp Phe
Trp Ile Phe Asp
Trp Ile Met Met
Trp Leu Asp Phe
Trp Leu Phe Asp
Trp Leu Met Met
Trp Met Phe Pro
Trp Met Ile Met
Trp Met Leu Met
Trp Met Met Ile
Trp Met Met Leu
Trp Met Pro Phe
Trp Asn Phe Asn
Trp Asn Asn Phe
Trp Pro Asp Tyr
Trp Pro Phe Met
Trp Pro Met Phe
Trp Pro Tyr Asp
Trp Thr His His
Trp Val Glu Phe
Trp Val Phe Glu
Trp Tyr Asp Pro
Trp Tyr Pro Asp
Tyr Asp Pro Trp
Tyr Asp Trp Pro
Tyr Glu Ile Arg
Tyr Glu Leu Arg
Tyr Glu Arg Ile
Tyr Glu Arg Leu
Tyr Phe His Asn
Tyr Phe Asn His
Tyr His Phe Asn
Tyr His Asn Phe
Tyr Ile Arg Glu
Tyr Leu Glu Arg
Tyr Leu Arg Glu
Tyr Asn Phe His
Tyr Asn His Phe
Tyr Asn Gln Arg
Tyr Asn Arg Gln
Tyr Pro Asp Trp
Tyr Pro Trp Asp
Tyr Gln Asn Arg
Tyr Gln Arg Asn
Tyr Arg Glu Ile
Tyr Arg Glu Leu
Tyr Arg Leu Glu
Tyr Arg Asn Gln
Tyr Arg Gln Asn
Tyr Trp Asp Pro
Tyr Trp Pro Asp
Taurochenodeoxycholic acid 7-sulfate
C26H45NO9S2 (579.2535600000001)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
2-[[(3a,5b,7b)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]amino], Ethanesulfonic acid
C26H45NO9S2 (579.2535600000001)
2-[[(3a,5b,12a)-3-hydroxy-24-oxo-12-(sulfooxy)cholan-24-yl]amino]-Ethanesulfonic acid
C26H45NO9S2 (579.2535600000001)
2-[[(3a,5b,7b)-7-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]amino]-Ethanesulfonic acid
C26H45NO9S2 (579.2535600000001)
2-[[(3a,5b,12a)-12-hydroxy-24-oxo-3-(sulfooxy)cholan-24-yl]amino]-Ethanesulfonic acid
C26H45NO9S2 (579.2535600000001)
Ethanesulfonic acid, 2-[[(3a,5b,7a)-3-hydroxy-24-oxo-7-(sulfooxy)cholan-24-yl]amino]
C26H45NO9S2 (579.2535600000001)
Taurochenodeoxycholic acid 3-sulfate
C26H45NO9S2 (579.2535600000001)
4-BROMO-N,N-BIS(4-((2-ETHYLHEXYL)OXY)PHENYL)ANILINE
C34H46BrNO2 (579.2711715999999)
Droloxifene citrate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D020011 - Protective Agents > D000975 - Antioxidants D000970 - Antineoplastic Agents C1892 - Chemopreventive Agent
FMOC-2-[[(6-T-BUTOXY-CARBONYL)HEXANOYL]PIPERAZIN-4-YL]-GLYCINE
rac-8,14-Bis(tert-butyldimethylsilyloxy) Efavirenz-d4
C26H33ClD4F3NO4Si2 (579.2152715120001)
Alk-fak inhibitor CEP-37440
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-Acetyl-N-[1-(1,1-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-O-phosphonotyrosinamide
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
3alpha-Sulfooxy-7alpha-hydroxy-5beta-cholan-24-oyl-taurine
C26H45NO9S2 (579.2535600000001)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Taurochenodeoxycholate-3-sulfate is a bile salt found in urine[1].
3alpha-Sulfooxy-12alpha-hydroxy-5beta-cholan-24-oyl-taurine
C26H45NO9S2 (579.2535600000001)
N2-[1-[methyl-(phenylmethyl)amino]-3-(2-naphthalenyl)-1-oxopropan-2-yl]-N1-(2-nitrophenyl)pyrrolidine-1,2-dicarboxamide
C33H33N5O5 (579.2481568000001)
1-[3-[(2R,4R)-2-[[4-(hydroxymethyl)phenyl]methoxy]-6-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]-3,4-dihydro-2H-pyran-4-yl]-1-indolyl]ethanone
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
(5S,6R,9R)-N-(2-chlorophenyl)-5-methoxy-3,6,9-trimethyl-2-oxo-14-(pyridine-2-carbonylamino)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-8-carboxamide
C30H34ClN5O5 (579.2248344000001)
(4R,7R,8S)-8-methoxy-N-(2-methoxyphenyl)-4,7,10-trimethyl-14-[[(5-methyl-3-isoxazolyl)-oxomethyl]amino]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide
N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C33H33N5O3S (579.2303988000001)
2-[(2R,4aS,12aS)-8-[[(3-cyanoanilino)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
C33H33N5O5 (579.2481568000001)
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
N-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(4-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C33H33N5O3S (579.2303988000001)
N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
(1S)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-[2-(4-morpholinyl)-1-oxoethyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(3,5-dimethyl-4-isoxazolyl)urea
N-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
N-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-4-fluorobenzenesulfonamide
C29H42FN3O6S (579.2778204000001)
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N,1-dimethylimidazole-4-sulfonamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C33H33N5O3S (579.2303988000001)
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(3-cyanophenyl)phenyl]-3-(2-hydroxyethyl)-N-(pyridin-4-ylmethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
C33H33N5O3S (579.2303988000001)
(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-2-[2-(4-morpholinyl)-1-oxoethyl]-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide
2-[[(4R)-4-[(3R,5S,7R,10S,13R,17R)-3-hydroxy-10,13-dimethyl-7-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
C26H45NO9S2 (579.2535600000001)
2-((4R)-4-((3R,5R,7R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO9S2 (579.2535600000001)
2-((4R)-4-((3R,5R,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO9S2 (579.2535600000001)
Taurochenodeoxycholate-7-sulfate
C26H45NO9S2 (579.2535600000001)
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Tauroursodeoxycholic acid 3-sulfate
C26H45NO9S2 (579.2535600000001)
methyl (4s,5s,6s)-4-{[(1r)-2-acetyl-6-hydroxy-7-methoxy-3,4-dihydro-1h-isoquinolin-1-yl]methyl}-5-ethenyl-6-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylate
C28H37NO12 (579.2315642000001)